Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Canntab Therapeutics Ltd C.PILL

Alternate Symbol(s):  CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and... see more

CSE:PILL - Post Discussion

Canntab Therapeutics Ltd > biggest scam ever here
View:
Post by vangooh on Sep 21, 2018 11:02am

biggest scam ever here

it should have been illegal what happened with this company
Comment by RandomGuy1 on Sep 21, 2018 11:04am
what?
Comment by Tonyde on Sep 21, 2018 6:22pm
vangooh, please enlighten me (us), what happened with this company that is / was so illegal??
Comment by vangooh on Sep 22, 2018 1:43pm
For those who invested before the halt and split it was almost criminal what happened lol luckily I only lost out in a few hundred but many lost ALOT more. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities